As CFAC pointed out 3 weeks ago in our article about Canadian statistics -- even worldwide -- now there is evidence of false information about the AIDs issue. -- CFAC

Sexually transmitted diseases (STD), AIDS and anal cancer: HIV positive homosexuals are 9000% more likely to develop anal cancer according to the February 2007 issue of the International Journal of STD and AIDS. 

Other medical problems from sodomy also have grave consequences.

See the three articles on the subject one at ::

http://www.familyaction.org/Articles/issues/sexuality/teen-stds.htm

others below.

The most preventable disease has become the most expensive

It is perhaps the most easily avoided disease in the nation, affects a minute portion of the population, yet consumes vast quantities of tax dollars. AIDS research has become the single most expensive component of our national medical research system given the small number of people it actually affects in Canada.

AIDS is the acronym for Acquired Immune Deficiency Syndrome: with the reference to 'syndrome' meaning medical researchers do not yet fully understand how AIDS develops. What is known is the syndrome weakens the human immune system substantially so that other, often usually harmless conditions, such as the common cold, can kill an AIDS sufferer. The Human Immuno-deficiency Virus, or HIV, is a blood-borne virus and is believed to be a significant factor in the development of AIDS, though many carriers of HIV never develop AIDS.

Despite the insistence of Health Canada, various provincial governments and the loud AIDS lobby, there is no 'epidemic' and never has been. In fact, in 2005, the latest year statistics are available, only 72 people across Canada are known to have died of AIDS. That's correct: of the approximately 234,000 Canadians who died in 2005, just 72 of those deaths were due to AIDS according to the federal government's Public Health Agency of Canada (PHAC). According to the PHAC, AIDS deaths peaked a decade earlier in 1995 when 1501 died of AIDS, up from 75 in 1985, the year statistics were first published for this disease.

Obviously somewhat embarrassed to be referring to the diminished death toll as an 'epidemic,' the PHAC published the following caveat with its latest numbers: "Deaths due to causes other than AIDS may be less likely to be reported to PHAC than deaths due to AIDS. For example, if a person living with AIDS is killed in a motor vehicle collision, PHAC may be less likely to receive an update than if the person died directly as a result of AIDS."

Of course, the PHAC statement is complete nonsense. If an individual died in a car accident, it does not matter to the statistics whether they were suffering from a congenital heart defect, AIDS or even bubonic plague at the time. There is also no reason to believe AIDS deaths are less likely to be reported now than, say, 10 years ago. The fact is, AIDS deaths have dropped dramatically from their mid-90s peak in Canada.

Among the possible reasons for the dramatic drop in the AIDS mortality rate is the treatment of those infected. In the Canadian medical system, an expensive cocktail of anti-viral drugs is given to sufferers, prolonging life for many years or even decades.

And, rather than affecting a broad cross section of the population or randomly infecting people as once predicted by AIDS activists, AIDS afflicts the same tiny and insular groups of people engaging in dangerous behavior that it always has. Homosexuals, intravenous drug users and prostitutes constitute virtually all the domestic cases. While each of these deaths is a tragedy they simply do not constitute the epidemic that AIDS activists and other irresponsible health officials keep insisting exists.

Indeed, the latest statistics published by the Ontario Ministry of Health demonstrate that HIV infection is almost exclusively a homosexual issue. In Toronto, homosexual men who engage in sex activity - often sodomy - with other men (MSM) are 196 times more likely to have HIV infection than men who do not. The report also indicates that 19.6% of the male homosexual population in Toronto, or 1 in 5, is HIV-infected.

Dr. Robert Remis, Professor of Public Health Sciences at the University of Toronto, who authored the study for the Health Ministry, states: "The higher HIV infection rates among MSM are likely due to the greater efficiency of HIV transmission through anal intercourse compared to vaginal intercourse and the higher number of sexual partners among MSM compared to heterosexuals."

Despite the small number of Canadians affected, for the past decade the federal government alone has been spending more than $40 million annually on AIDS related research and 'educational' activities. Not to be outdone by the Chretien-Martin Liberals, in February Prime Minister Stephen Harper announced a further $111 million in funding for the Canadian HIV Vaccine Initiative which will engage in additional medical research.

The provincial governments across Canada are no better when it comes to blowing taxpayers' money on the non-epidemic of AIDS. The Ontario Government, for example, spent $54 million in 2006 on HIV-related research, care, treatment, prevention and support services, including $3.25 million for ongoing HIV prevention programs. Such 'prevention programs' often take the form of pornographic pamphlets and other advertising promoting condom use, while doing nothing to discourage the harmful activities which cause AIDS.

To be fair, AIDS, and HIV, the virus believed to be a key infectious element in the development of full-blown AIDS, are affecting larger portions of the population in several other countries in the world, most notably in sub-Saharan Africa. Some nations, such as Botswana, have seen significant percentages of the population afflicted by AIDS and it has become a leading cause of adult death, alongside diseases such as malaria. As such, any successful medical research in Canada and other Western nations may well benefit those afflicted in Africa one day.

Yet, even the spending of limited medical research dollars on AIDS research in the hope helping Africans remains questionable given that AIDS is almost entirely preventable.

Take Uganda as a case in point. Uganda, an East African nation of 15 million people, was once known of the Pearl of Africa before years of civil war and a subsequent AIDS crisis killed tens of thousands. However, after recognizing the truth that the only way to prevent AIDS is by promoting abstinence and monogamy, the Government of Uganda has managed to reduce the rate of HIV infection substantially among younger Ugandans as compared to earlier generations.

According to a study by researchers from Cambridge University and published in the April 2004 edition of Science, HIV prevalence in pregnant Ugandan women aged 15-24 peaked at 21% in 1991, but by 1998 had fallen to 9.7%.

The researchers themselves attributed the dramatic decline in HIV prevalence to a later average age of sexual debut, and a reduction in the number of sexual partners, backed by a consistent message from the Ugandan government. The Catholic and Anglican churches in Uganda have also played a key role in promoting sexual morality. "The outcome was equivalent to a highly effective vaccine," the researchers stated.

So is spending millions of Canadian tax dollars on the search for an HIV vaccine really a sensible use of our limited health care resources?

To answer this question, one might well consider the amount of government funding made available in the search for the cure and treatment of other diseases. For instance, in 2005, the year 72 Canadians died of AIDS, approximately 67,000 deaths occurred due to various cancers, and 72,000 deaths occurred due to cardiovascular disease, according to Statistics Canada.

Government spending on pure medical research on cancer and heart disease falls within a similar range to that of AIDS, with taxpayers spending, for example, $52 million annually at the federal level for the Canadian Cancer Control Strategy, and the provinces contributing several more millions.

Although the funding for these chronic and in many cases unpreventable diseases is in a similar range to spending on AIDS, these diseases kill approximately 1,000 times more Canadians every year. The level of government funding AIDS research receives may have developed through genuine compassion, but it is grossly disproportionate to funding for other chronic and fatal conditions.

So why do AIDS advocates, health officials and others continue to inflate the AIDS issue into a crisis, even though they know better than anyone it does not exist?

The answer may be quite simple in many cases: there is a lot of money to be made for a few.

Drug companies and condom manufacturers stand to benefit from sales, and a legion of activists and health bureaucrats depend on public perception that an 'epidemic' exists to maintain high levels of government funding and thus their high-paying jobs.

The multi-billion dollar industry that has been generated surrounding the promotion of the disease finds regular expression in celebrity-studded international conferences. The latest such event was held in Toronto in a circus-like atmosphere. Presenters predictably promoted so-called safe-needle sites and condoms, but the success of abstinence-based programs was ignored. Dr. Robert Gallo, the co-discoverer of AIDS in the 1980s, and who did not attend, criticized the Toronto conference as "irrelevant" and "silly." He added that if it takes celebrities to get people to attend such conferences, "then you've got the wrong people coming."

Pro-family activists have an opportunity to help restore some sanity to this situation by taking some key actions. Contact your local federal MP and provincial MLA. Ask them how much their government is spending on AIDS and how seriously this disease is affecting the population, compared to cancer and heart disease.

And then ask the important question: why a disproportionate amount is spent on AIDS when so few are affected. Demand balanced and responsible use of your tax dollars.

Scientists Acknowledge AIDS Crisis is Distorted and Overblown

Former UN Aids scientist charges UN ignoring its report indicating epidemic has stabilized or is in decline because of behaviour changes

(LifeSiteNews.com) - An increasing number of scientists are acknowledging that the AIDS crisis, in Africa and worldwide, is seriously distorted and overblown by international agencies and corporations, who in many cases tend to profit from the confusion. In recent months, more of these researchers have been speaking out against a wealthy and powerful establishment that consistently ignores fundamental facts regarding HIV and AIDS.

The controversy stems from a fundamental disagreement over almost every issue regarding AIDS transmission, prevalence, and prevention. While the United Nations Joint Program on HIV/AIDS (UNAIDS) and other international agencies insist that AIDS is a growing global epidemic that must be treated with massive condom distribution, sex education, and drug treatments, several high-profile scientists call the picture a "distortion". They say that AIDS statistics are overblown, and argue that the best means of prevention is abstinence and marital fidelity.

Dr. James Chin was the former head of a World Health Organization Global Programme on Aids unit from 1987-1992 and is currently a public health professor at UC Berkeley. He noted in a recent interview that in reality, the AIDS "pandemic" is not as widespread as it is often portrayed, and not even in large parts of Africa, where rates of infection with the Human Immunodeficiency Virus (HIV) vary widely.

"In South Africa, close to 20 percent of the adult population is infected with HIV, whereas in Ghana, it is only 2 to 3 percent of the population, and in Senegal, less than one percent is infected," Chin told Cybercast News Service.

In a separate interview with LifeSiteNews, Chin stated that the differences between these nations and countries like South Africa and Zimbabwe, where the rate of HIV infection is as high as 20 percent of the adult population, is at least in part due to behavioral differences, including sexual behavior. "In general, there are lower prevalence of sexual risk behaviors and HIV facilitating factors in West African populations compared to Eastern and Southern African populations," he said.

Chin added that the United Nations Joint Program on HIV/AIDS (UNAIDS), has refused to acknowledge its own studies showing that the epidemic has stabilized or is in decline.

"Up to 2006, UNAIDS maintained its position that the pandemic was "ever-increasing and ever expanding", noted Chin. "However in its May 2006 report to the UN, UNAIDS acknowledged that - 'Overall globally, the HIV incidence rate (the annual number of new HIV infections as a proportion of previously uninfected persons) is believed to have peaked in the late 1990s and to have stabilized subsequently, notwithstanding increasing incidence in a number of countries.'"

Chin also quoted the report's admission that "changes in behavior" are at the root of the success. "In several countries, favourable trends in incidence are related to changes in behaviour and prevention programs. Changes in incidence along with rising AIDS mortality have caused global HIV prevalence (the proportion of people living with HIV) to level off," the report states.

"Since this report to the UN, I haven't seen much reference to the "peaking" of global HIV incidence by the late 1990s - almost a decade ago - you should ask UNAIDS why they have not mentioned this more since then!" Chin told LifeSite.

Disease has Become a "Billion Dollar Industry" that Stands to Profit from Misinformation

Dr. James Chin has recently published a book detailing his struggles with the UNAIDS establishment. Titled "The AIDS Pandemic: The Collision of Epidemiology with Political Correctness", the book's thesis is that "the story of HIV has been distorted by UNAIDS and AIDS activists in order to support the myth of the high potential risk of HIV epidemics spreading into the general population" according to the publisher.

Chin's criticisms are echoed by two other eminent scientists at Harvard's Center on Population and Development, Dr. Edward Green and Dr. Daniel Halperin, whose research continues to be ignored by the AIDS establishment. Dr. Green has served as team leader on numerous USAID project designs and evaluations. Dr. Halpern is a former Technical Adviser for Prevention/Behaviour Change, USAID Southern Africa Regional HIV/AIDS Program.

The two Harvard scientists have noted that, while abstinence programs in countries like Uganda have proven their effectiveness, AIDS policymakers continue to promote condom use, and ignore the differences in AIDS rates among African antions.

Halperin points out that the most serious cases of high-frequency infection are confined to only 10 Sub-Saharan African nations, less than 25% of the countries of the region. "There are about 10 nations, all of them in Southern Africa, that have very bad epidemics," Halperin told Cybercast News Service. "Outside of those countries, for the most part, the rest of the world is not nearly as affected, although there are certain risk groups within some countries which have extremely high rates of HIV."

Green has written a book on Uganda's "ABC" approach to HIV transmission: first Abstinence, then Be Faithful, then if the first two fail, use a Condom. Uganda's immediate response to the AIDS threat in the early 1980s reduced the incidence of HIV infection from 15% to less than 4% in the space of a few years. Green's book examines the strange disconnect between the demonstrated effectiveness of abstinence and marital fidelity campaigns and the prevention strategies of international aid agencies.

In an article for the journal The Responsive Community, Green points out the utter failure of the condom-pushing approach of UNAIDS. "How has the Western risk-reduction model fared in Africa? There is no evidence that mass promotion of condoms has paid off with a decline of HIV infection rates at the population level in Africa, according to a new UNAIDS assessment of condom effectiveness. In fact, countries with the highest levels of condom availability (Zimbabwe, Botswana, South Africa, Kenya) also have some of the highest HIV prevalence rates in the world," he writes.

Green notes that the insistence on promoting failed policies can be explained in part by a cultural bias in favor of sexual promiscuity and permissiveness, but adds that an important factor may also be the economic interests of the global AIDS establishment. "Apart from Western values and biases, there are economic factors to consider. AIDS prevention has become a billion dollar industry" he writes. "Under President Bush's global AIDS initiative, the US will spend $15 billion, partially on prevention. It would be politically naive to expect that those who profit from the lucrative AIDS-prevention industry would not be inclined to protect their interests."

"Those who work in condom promotion and STD treatment, as well as the industries that supply these devices and drugs, do not want to lose market share, so to speak, to those few who have begun to talk about behavior. Put crudely, who makes a buck if Africans simply start being monogamous?"

Green's statement about organizations "protecting their interests" has proven to be prophetic. Since the initiation of the US program, which promotes abstinence as part of its approach to prevention, it has suffered continuous attacks by the global AIDS establishment, which is rigidly opposed to any serious discussion of the benefits of abstinence and marital fidelity. And despite their impeccable establishment credentials as research scientists affiliated with major universities, scientists like Green are accused of "AIDS denialism".

When Bill Gates, founder of Microsoft, merely mentioned abstinence and marital fidelity as part of the solution to the problem at an AIDS conference in Toronto last year, he was roundly booed by the audience. However, when he played down such "politically incorrect" solutions and began to speak of condom distribution, he was met with enthusiastic cheering (see LifeSiteNews coverage at http://www.lifesite.net/ldn/2006/aug/06081403.html).

Despite the increasingly well-known facts about HIV transmission and prevention, certain proposals simply remain socially unacceptable among the apparatchiks of the international AIDS bureaucracy. With billions of dollars of government aid money on the line, the status quo is likely to continue with saving lives kept to a low priority.

More costs for preventable disease

Dr. Bernstein's appointment comes after the recent announcements by Merck, the HIV Vaccine Trials Network (HVTN) and the National Institute of Allergy and Infectious Diseases (NIAID) regarding the discontinuation of immunizations in the STEP HIV vaccine trial.

"The scientific challenges of developing an HIV vaccine are enormous, but the Enterprise's collaborative vision is a source of tremendous hope," said Dr. Bernstein. "The challenge now is to build on this momentum and implement a coherent, integrated and global scientific strategy that will hasten development of an effective and safe vaccine. The world expects nothing less of all those engaged in this endeavor."

The Global HIV Vaccine Enterprise is charged by its founders with setting scientific priorities, mobilizing resources, and improving collaboration in the HIV vaccine field. Originally proposed by 24 leading HIV vaccine researchers in 2003, the Enterprise has to date mobilized more than US$750 million in support of its scientific plan. The Enterprise's plan focuses on six key research areas: vaccine discovery, laboratory standardization, product development and manufacturing, clinical trials capacity, regulatory issues and intellectual property.

"I'm proud to see one of Canada's top scientists leading the Enterprise," said Stephen Lewis, former UN Envoy on HIV/AIDS in Africa, and co-director of AIDS-Free World. "Alan Bernstein is an ideal choice to serve as a leader among leaders, coordinating the HIV vaccine field and working to build productive partnerships between researchers, donors, and advocates."

The Enterprise today also announced the opening of its first independent secretariat in New York and new funding commitments to support the coordinating role of the secretariat. The US National Institute of Allergy and Infectious Diseases (NIAID), part of the US National Institutes of Health (NIH), has awarded up to US$7 million over the next seven years, and the Bill & Melinda Gates Foundation has committed $20 million over the next four years, to support the secretariat's activities.

"The enormous scientific obstacles in identifying an effective HIV vaccine combined with the urgent need for improved HIV prevention support the need for increased coordination and collaboration globally to accelerate progress," said Anthony S. Fauci, M.D., Director of NIAID. "Dr. Bernstein has a proven track record building a world-class scientific organization that brings together researchers, funders, advocates and industry. The Enterprise, under Dr. Bernstein's leadership, can bring new energy to the HIV vaccine field and help us work together in a coordinated manner to tackle these major obstacles as quickly as possible."

Dr. Bernstein was previously the founding president of the Canadian Institutes of Health Research. Over the past seven years, he has built CIHR into one of the world's leading research agencies, supporting more than 11,000 health researchers with an annual budget of $1 billion.

"Alan Bernstein's appointment as executive director brings increased momentum to the Enterprise's essential efforts to help accelerate the search for an HIV vaccine," said Dr. Seth Berkley, President and CEO of the International AIDS Vaccine Initiative. "This is a wonderful opportunity for those of us working in the field to derive an added level of synergy by working together across all stages of HIV vaccine development."

"The Enterprise has an important role to play in ensuring that HIV vaccine development efforts match the magnitude of the pandemic. The 2005 Enterprise scientific plan charts a broad path forward - we must explore multiple approaches and aggressively pursue novel scientific leads, working together in new ways," said Dr. José Esparza, senior advisor on HIV vaccines for the Bill & Melinda Gates Foundation. "The Gates Foundation is committed to supporting the Enterprise secretariat, and to helping advance priorities in the Enterprise scientific plan through our support of the Collaboration for AIDS Vaccine Discovery."

Dr. Bernstein received his Ph.D. in Medical Biophysics at the University of Toronto. Following postdoctoral work in London where he first began working on retroviruses, he returned to Canada to join the faculty of the Ontario Cancer Institute. He later served as head of the Division of Molecular and Developmental Biology at the Samuel Lunenfeld Research Institute at Mount Sinai Hospital, and then its director of research.

An internationally renowned researcher, he has made extensive contributions to the study of embryonic development, hematopoiesis and cancer. Dr. Bernstein has received a number of national and international awards for his research, and has served on a large number of international scientific bodies, including the scientific board of the Grand Challenges in Global Health initiative.

"HIV affects more than 40 million people worldwide, and nearly 5 million people are newly infected every year," said Dr. Helene Gayle, President and CEO of CARE and chair of the Enterprise coordinating committee. "An HIV vaccine, once developed, has the potential to save millions of lives and stop this pandemic. The Enterprise can speed the day when AIDS will no longer threaten us or our children."

About the Global HIV Vaccine Enterprise:

The Global HIV Vaccine Enterprise is an alliance of independent organizations around the world dedicated to accelerating the development of a preventive HIV vaccine by implementing a shared scientific plan, mobilizing significant new funding for vaccine research, and promoting more efficient, faster ways for researchers to share successes and failures and avoid duplicating their efforts. The Enterprise brings together researchers, funders, and advocates from academia, government agencies, private industry, and non-governmental organizations in developed and developing countries. The Enterprise also engages the broader international community to support HIV vaccine research and make it an integral part of the global response to HIV/AIDS. www.hivvaccineenterprise.org/.